IDH1 and oligodendroglioma: For patients with newly diagnosed grade 2 oligodendroglioma, postoperative management strategies, outside the context of clinical trials, typically encompass watchful waiting, radiotherapy (RT) combined with chemotherapy, and IDH-targeted therapy.